Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
EspaƱol
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
GABAA Modulation as a Target for Developing Medications for Methamphetamine Abuse
Rush, Craig
(PI)
Glaser, Paul
(CoI)
Hays, Lon
(CoI)
Stoops, William
(CoI)
Lile, Joshua
(Former CoI)
Behavioral Science
Psychiatry
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Neuroscience
Receptor Modulator
100%
GABAA Receptor
100%
Drug Therapy
50%
Drug Self-Administration
33%
Gamma-Aminobutyric Acid
33%
Methamphetamine Dependence
33%
Dopamine
33%
Analeptic
16%
Behavior (Neuroscience)
16%
Drug Discrimination
16%
Receptor Modulation
16%
Behavioral Effect
16%
Placebo
16%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Pharmacotherapy
42%
Subjective Effects
28%
4 Aminobutyric Acid
28%
Methamphetamine Dependence
28%
Dopamine
28%
Experimental Animal
14%
Preclinical Study
14%
Behavioral Effect
14%
Placebo
14%